info@seagull-health.com
SeagullHealth
语言:
search
new
Side effects of Quviviq
501
Article source: Seagull Pharmacy
Jul 02, 2025

Quviviq is a drug for treating insomnia in adults. Like other drugs, Quviviq may also be accompanied by a series of side effects during use. This article aims to explore the side effects of Quviviq, the corresponding mitigation measures, and the precautions for daily use, so as to help patients use this drug effectively.

Side effects of Quviviq

Quviviq may also cause a series of adverse reactions while treating insomnia, affecting the patient's daily life.

Nervous system reactions

The most common adverse reactions include headache and drowsiness or fatigue, with an incidence of more than 5%. These symptoms may directly affect the patient's daily work and life, leading to problems such as inattention and memory loss. Some patients may also experience neurological symptoms such as dizziness and paresthesia. Although these symptoms are not common, they should be taken seriously once they occur.

Psychiatric symptoms

Quviviq may also cause or aggravate the patient's mental illness symptoms, such as depression and anxiety. Especially in patients with existing depression, the use of Quviviq may worsen depression and even lead to suicidal thoughts. The drug may also cause psychiatric symptoms such as sleep paralysis and hypnotic hallucinations, posing a potential threat to the patient's mental health.

The side effects of Daridorexant involve the nervous system, mental health and multiple systems of the whole body. Patients should always be vigilant during medication and communicate with doctors in a timely manner.

Measures to alleviate the side effects of Daridorexant

For the side effects of Daridorexant, patients can take a series of measures to alleviate them to improve the effectiveness and comfort of medication.

Adjust the dosage of medication

For patients with mild side effects, the dosage of medication can be appropriately adjusted under the guidance of a doctor. For example, reduce the dosage or change the medication time to reduce the stimulation of the drug to the body.

Be cautious when taking combined medications

Daridorexant may interact with other drugs when used in combination, increasing the risk of side effects. Patients should inform their doctors of their medication history in detail before taking the medication to avoid taking it in combination with strong or moderate CYP3A4 inhibitors, inducers and other drugs.

Through reasonable medication adjustments and lifestyle improvements, patients can effectively alleviate the side effects of Daridorexant and improve their quality of life.

Daily precautions for Daridorexant

Patients should also pay attention to the following points when using Daridorexant in daily life.

Strictly follow the doctor's instructions

Patients should strictly follow the doctor's instructions to take the medicine and should not change the dosage or time of medication without authorization. Regular follow-up visits should be made to report the effects and side effects of the medication to the doctor.

Monitor physical condition

During the medication process, patients should pay close attention to their physical condition. If serious side effects or discomfort symptoms occur, they should stop taking the medicine immediately and seek medical treatment. In particular, special groups such as elderly patients and patients with liver damage need to strengthen physical monitoring.

By following the doctor's instructions, monitoring physical condition and other daily precautions, patients can use Daridorexant more effectively, reduce the occurrence of side effects, and improve treatment effects.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Quviviq(Daridorexant)
Quviviq(Daridorexant)
Adult patients with difficulty initiating and/or maintaining sleep.
WeChat Scan
Free Inquiry
Recommended Articles
Precautions for Daridorexant
Daridorexant (QUVIVIQ) is a drug used to treat insomnia in adults and belongs to a class of drugs called orexin receptor antagonists. This drug helps improve sleep quality and promote sleep onset...
How effective is Quviviq(Daridorexant) in treatment?
Quviviq(Daridorexant) is a new dual orexin receptor antagonist that has shown significant effects in the treatment of insomnia in adults. Daridorexant can significantly reduce the time it ta...
Quviviq Usage and Dosage
Quviviq is an innovative drug for the treatment of insomnia, and its usage and dosage must strictly follow professional guidance. This article will give a detailed introduction to the usage and dosage...
Precautions for use of Adagrasib
Adagrasib is an important therapeutic drug, and its correct use and precautions are crucial to ensure the therapeutic effect.Precautions for use of AdagrasibUnderstanding and following the precau...
Indications of Relugolix
Relugolix, also known as MYFEMBREE, is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist. It blocks the binding of endogenous GnRH to its receptor, reduces the release of luteinizing h...
Relugolix tablet instructions
Relugolix tablets are a drug used to treat heavy menstrual bleeding and moderate to severe pain caused by uterine fibroids or endometriosis in premenopausal women. Relugolix has not yet been...
Relugolix tablets price
Relugolix tablets are a drug used to treat heavy menstrual bleeding and endometriosis pain associated with uterine fibroids, and are produced by Takeda Corporation of Japan. This article will int...
Relugolix purchase channels
The main ingredient of MYFEMBREE is Relugolix, which can block the binding of endogenous GnRH to GnRH receptors, inhibit the synthesis and release of gonadotropins such as luteinizing hormone and foll...
Related Articles
What Are the Side Effects of Daridorexant (Quviviq)?
Daridorexant (Quviviq) is a novel orexin receptor antagonist that was approved in the United States in January 2022 for the treatment of insomnia in adults, specifically targeting patients with diffic...
How Effective is Daridorexant (Quviviq) in Treatment?
As a new-generation orexin receptor antagonist, daridorexant (Quviviq) improves sleep quality through a unique mechanism, providing a new treatment option for patients with insomnia.How Effective is D...
Precautions for Daridorexant (Quviviq) Administration
Daridorexant (Quviviq) is a novel orexin receptor antagonist indicated for the treatment of insomnia in adults, particularly targeting difficulties with sleep onset and sleep maintenance. As a prescri...
How to Use Daridorexant (Quviviq)
Daridorexant (Quviviq) is a novel orexin receptor antagonist indicated for the treatment of insomnia in adults, particularly targeting difficulties with sleep onset and sleep maintenance.How to Use Da...
Side effects of Quviviq
Quviviq is a drug for treating insomnia in adults. Like other drugs, Quviviq may also be accompanied by a series of side effects during use. This article aims to explore the side effects of ...
Precautions for Daridorexant
Daridorexant (QUVIVIQ) is a drug used to treat insomnia in adults and belongs to a class of drugs called orexin receptor antagonists. This drug helps improve sleep quality and promote sleep onset...
How effective is Quviviq(Daridorexant) in treatment?
Quviviq(Daridorexant) is a new dual orexin receptor antagonist that has shown significant effects in the treatment of insomnia in adults. Daridorexant can significantly reduce the time it ta...
Quviviq Usage and Dosage
Quviviq is an innovative drug for the treatment of insomnia, and its usage and dosage must strictly follow professional guidance. This article will give a detailed introduction to the usage and dosage...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved